Bruce Eaton joined SomaLogic as COO in November of 2011. Prior to joining SomaLogic he was the Chairman of the Department of Chemistry and Biochemistry at the University of Colorado Boulder. He has been engaged in commercial biotechnology since 1981. Dr. Eaton is named as either inventor or co-inventor on over 70 issued patents world-wide. He has served as consultant to a variety of biotechnology companies leading to successful product launches and two successful company IPO’s. From 2004-2005, he directed the research efforts at SomaLogic and served as a senior advisor to the company until 2011. Prior to that, Dr. Eaton was the President and Founder of Invenux, Inc., a tools-based drug discovery company. He was also instrumental in founding Cropsolution, Inc. in 2000, an agrichemical discovery company. From 1995-1999, Dr. Eaton was the Vice President of Chemistry with global responsibility and directed the efforts of over 50 scientists at NeXstar Pharmaceuticals, including the group responsible for the production of the first successful aptamer IND, NX1838 now known as Macugen™ (Eyetech Pharmaceuticals), for age-related macular degeneration.